Download presentation
Presentation is loading. Please wait.
Published byRichard Patterson Modified over 8 years ago
1
Date of download: 6/21/2016 From: Pharmacist-led Chronic Disease Management: A Systematic Review of Effectiveness and Harms Compared With Usual Care Ann Intern Med. Published online April 26, 2016. doi:10.7326/M15-3058 Components of pharmacist-led chronic disease management. * Follow-up after prescription for medication effectiveness and safety and drug-related problems. † Includes medication reconciliation. ‡ The pharmacist provides immunization, which was not an outcome of interest. § Facilitate access to other health care professionals and provide education about disease, lifestyle changes, aspirin therapy, and tobacco cessation. Figure Legend: Copyright © American College of Physicians. All rights reserved.American College of Physicians
2
Date of download: 6/21/2016 From: Pharmacist-led Chronic Disease Management: A Systematic Review of Effectiveness and Harms Compared With Usual Care Ann Intern Med. Published online April 26, 2016. doi:10.7326/M15-3058 Summary of evidence search and selection. CCT = controlled clinical trial; IPA = International Pharmaceutical Abstracts; RCT = randomized, controlled trial. Figure Legend: Copyright © American College of Physicians. All rights reserved.American College of Physicians
3
Date of download: 6/21/2016 From: Pharmacist-led Chronic Disease Management: A Systematic Review of Effectiveness and Harms Compared With Usual Care Ann Intern Med. Published online April 26, 2016. doi:10.7326/M15-3058 Goal attainment for diabetes, dyslipidemia, hypertension, and polypharmacy studies, by primary outcome. Risk ratios were calculated by using Mantel–Haenszel random-effects models. BP = blood pressure, HbA 1c = hemoglobin A 1c ; LDL-C = low-density lipoprotein cholesterol. Figure Legend: Copyright © American College of Physicians. All rights reserved.American College of Physicians
Similar presentations
© 2024 SlidePlayer.com Inc.
All rights reserved.